A detailed history of Bank Of Montreal transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 8,036 shares of LNTH stock, worth $732,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,036
Previous 10,584 24.07%
Holding current value
$732,642
Previous $658,000 1.98%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$58.87 - $83.05 $150,000 - $211,611
-2,548 Reduced 24.07%
8,036 $645,000
Q1 2024

May 13, 2024

BUY
$51.07 - $68.26 $192,533 - $257,340
3,770 Added 55.33%
10,584 $658,000
Q4 2023

Feb 08, 2024

SELL
$55.6 - $77.89 $196,268 - $274,951
-3,530 Reduced 34.13%
6,814 $422,000
Q3 2023

Nov 01, 2023

BUY
$60.27 - $90.75 $91,670 - $138,030
1,521 Added 17.24%
10,344 $718,000
Q2 2023

Aug 02, 2023

SELL
$82.41 - $99.65 $4.6 Million - $5.56 Million
-55,794 Reduced 86.35%
8,823 $740,000
Q1 2023

Jun 13, 2024

BUY
$47.76 - $82.86 $449,087 - $779,132
9,403 Added 88.84%
19,987 $1.65 Million
Q4 2022

Feb 01, 2023

BUY
$48.76 - $77.67 $2.77 Million - $4.42 Million
56,865 Added 733.55%
64,617 $3.29 Million
Q3 2022

Nov 10, 2022

SELL
$61.42 - $86.29 $7.11 Million - $9.99 Million
-115,749 Reduced 93.72%
7,752 $561,000
Q2 2022

Aug 11, 2022

BUY
$55.54 - $72.65 $5.84 Million - $7.64 Million
105,222 Added 575.64%
123,501 $8.21 Million
Q1 2022

May 12, 2022

BUY
$24.28 - $56.64 $7,356 - $17,161
303 Added 1.69%
18,279 $1.03 Million
Q4 2021

Feb 11, 2022

SELL
$22.54 - $30.44 $74,945 - $101,213
-3,325 Reduced 15.61%
17,976 $539,000
Q3 2021

Nov 12, 2021

SELL
$24.23 - $28.59 $3.07 Million - $3.62 Million
-126,600 Reduced 85.6%
21,301 $555,000
Q2 2021

Aug 12, 2021

BUY
$19.51 - $27.64 $2.89 Million - $4.09 Million
147,901 New
147,901 $4.09 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.27B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.